SCHEMBL20271560

SCHEMBL20271560

Cc1cc(/N=N/c2ccc(S(=O)(=O)N3CCCC3)cc2)cc(C)c1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.67
▸ TDP1 Q9NUW8 3/20 0.67
▸ NPC1 O15118 2/20 0.67
▸ RAB9A P51151 2/20 0.67
▸ MAPK1 P28482 1/20 0.67
▸ ALDH1A1 P00352 7/20 0.55
▸ HPGD P15428 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ MEN1 O00255 6/20 0.53
▸ KMT2A Q03164 6/20 0.53
▸ GAA P10253 2/20 0.53
▸ USP2 O75604 1/20 0.53
▸ PHLPP2 Q6ZVD8 1/20 0.52
▸ POLB P06746 3/20 0.52
▸ PKM P14618 3/20 0.51
▸ ALOX12 P18054 1/20 0.51
▸ CASP3 P42574 1/20 0.51
▸ SENP8 Q96LD8 1/20 0.51
▸ SENP7 Q9BQF6 1/20 0.51
▸ SENP6 Q9GZR1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23787111 1.00 MAPT (0.67) MAPTTDP1NPC1RAB9AMAPK1
SCHEMBL20271467 0.80 MAPT (0.66) MAPTTDP1NPC1RAB9AMAPK1
SCHEMBL23787102 0.80 MAPT (0.66) MAPTTDP1NPC1RAB9AMAPK1
SCHEMBL8843749 0.80 PHLPP2 (0.75) PHLPP2POLBBRD4
SCHEMBL8843743 0.80 PHLPP2 (0.75) PHLPP2POLBBRD4
SCHEMBL9616947 0.74 ALDH1A1 (0.69) MAPTTDP1NPC1RAB9AMAPK1
SCHEMBL1046239 0.72 USP2 (0.76) MAPTTDP1NPC1RAB9AALDH1A1
SCHEMBL436674 0.72 PKM (0.89) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL13901737 0.72 USP2 (0.74) ALDH1A1LMNAMEN1KMT2AGAA
SCHEMBL20271957 0.71 BRD4 (0.68) ALDH1A1LMNAMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3554503-B1 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) UNIV TEXAS (US) 2023-10-04 — — EP disclosed
EP-3554503-B1 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) UNIV TEXAS (US) 2023-10-04 — — EP disclosed
US-11117865-B2 Inhibitors of bromodomain-containing protein 4 (BRD4) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-09-14 — — US disclosed
US-11117865-B2 Inhibitors of bromodomain-containing protein 4 (BRD4) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-09-14 — — US disclosed
EP-3554503-A1 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) Zhou, Jia (US) 2019-10-23 — — EP disclosed
CN-110267660-A The inhibitor of domain protein containing Bu Luomo 4 (BRD4) 德克萨斯大学系统董事会 2019-09-20 — — CN disclosed
WO-2018112037-A1 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) ZHOU JIA (US) 2018-06-21 — — WO disclosed
WO-2018112037-A1 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) ZHOU JIA (US) 2018-06-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11117865-B2 Inhibitors of bromodomain-containing protein 4 (BRD4) BRD4, NFKBIA, NFRKB MAPT 1988/4885TDP1 2864/4885NPC1 1502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback